Hans MENSSEN

Person

Basel, CH

People

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION THERAPIES WITH VENETOCLAX AND TIM-3 INHIBITORS
- Publication number 20240301053
- Publication date Sep 12, 2024
- Novartis AG
- Hans Menssen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TIM-3 INHIBITORS AND USES THEREOF
- Publication number 20240301054
- Publication date Sep 12, 2024
- Novartis AG
- K. Gary J. Vanasse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF an anti-P-selectin antibody
- Publication number 20240190971
- Publication date Jun 13, 2024
- Novartis AG
- Shalini CHATURVEDI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF AN ERK INHIBITOR FOR THE TREATMENT OF MYELOFIBROSIS
- Publication number 20240000777
- Publication date Jan 4, 2024
- Novartis AG
- Sime BRKIC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AN ERK INHIBITOR FOR THE TREATMENT OF MYELOFIBROSIS
- Publication number 20230372334
- Publication date Nov 23, 2023
- Novartis AG
- Sime BRKIC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MDM2 INHIBITORS FOR USE IN THE TREATMENT OR PREVENTION OF HEMATOLOG...
- Publication number 20230338374
- Publication date Oct 26, 2023
- Novartis AG
- Robert Zeiser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION COMPRISING A TIM-3 INHIBITOR AND A HYPOMETHYLATING AGEN...
- Publication number 20230058489
- Publication date Feb 23, 2023
- Novartis AG
- Hans MENSSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AN MDM2 INHIBITOR FOR THE TREATMENT OF MYELOFIBROSIS
- Publication number 20220331318
- Publication date Oct 20, 2022
- Novartis AG
- Asa Eliasson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF HIGH-AFFINITY, LIGAND-BLOCKING, HUMANIZED ANTI-T-CELL IMMUNO...
- Publication number 20220306737
- Publication date Sep 29, 2022
- Novartis AG
- Asa Eliasson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF an anti-P-selectin antibody
- Publication number 20210002374
- Publication date Jan 7, 2021
- Novartis AG
- Shalini CHATURVEDI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Hans MENSSEN

Person

Patents Applicationslast 30 patents

COMBINATION THERAPIES WITH VENETOCLAX AND TIM-3 INHIBITORS

TIM-3 INHIBITORS AND USES THEREOF

USE OF an anti-P-selectin antibody

USE OF AN ERK INHIBITOR FOR THE TREATMENT OF MYELOFIBROSIS

USE OF AN ERK INHIBITOR FOR THE TREATMENT OF MYELOFIBROSIS

MDM2 INHIBITORS FOR USE IN THE TREATMENT OR PREVENTION OF HEMATOLOG...

COMBINATION COMPRISING A TIM-3 INHIBITOR AND A HYPOMETHYLATING AGEN...

USE OF AN MDM2 INHIBITOR FOR THE TREATMENT OF MYELOFIBROSIS

USE OF HIGH-AFFINITY, LIGAND-BLOCKING, HUMANIZED ANTI-T-CELL IMMUNO...

USE OF an anti-P-selectin antibody